暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
SHTDY 国药控股(ADR)
- 12.600
- +0.080+0.64%
延时15分钟行情收盘价 05/03 15:59 (美东)
78.64亿总市值6.29市盈率TTM
12.960最高价12.530最低价7214股成交量12.960今开12.520昨收9.06万成交额0.00%换手率6.29市盈率(静)6.24亿总股本16.94052周最高0.76市净率78.64亿流通值11.35552周最低0.59股息TTM6.24亿流通股24.356历史最高4.66%股息率TTM3.44%振幅7.620历史最低12.552平均价1股每手
盘后分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
*高盛微降國藥(01099.HK)目標價至21.17元 首季業績疲弱
*高盛微降國藥(01099.HK)目標價至21.17元 首季業績疲弱
你应该考虑收购国药集团股份有限公司吗Ltd. (HKG: 1099) 现在？
国药控股有限公司Ltd.（HKG: 1099）并不是目前最大的公司，但在过去的几个月中，它在香港交易所的股价上涨了两位数，涨幅超过10％。股东可能会出席
国药控股(01099.HK)：主营业务保持增长态势 转型创新持续推进
*大摩降國藥(01099.HK)目標價至27元 評級「增持」
*大摩降國藥(01099.HK)目標價至27元 評級「增持」
《港股》恒指升35点 油股及航运股涨 汇控靠稳
美股道指升146点或0.4%，港股「六连升」后今日(30日)持续升势，恒指高开96点，升幅其后扩大至155点见17,902点，半日升35点或0.2%，报17,782点；国指升7点或0.1%，报6,290点；恒生科技指数跌5点或0.2%，报3,707点。大市半日成交总额647.8亿元，沪、深港通南下交易半日净流入28.85亿及14.04亿元人民币。油股上涨，中石化(00386.HK)及中海油(008
国药季赚14亿倒退一成
评论
Analysts have downgraded their earnings per share estimates for Sinopharm Group, indicating a decline in sentiment. They also suggest that Sinopharm may underperform compared to the wider industry, but the consensus price target remains steady.
Earnings Update: Sinopharm Group Co. Ltd. (HKG:1099) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts 2
$国药控股(01099.HK$ *大和首予國藥(01099.HK)「買入」評級 目標價25元
Sinopharm Group's declining ROCE trend is concerning. Increased capital investment without matching sales suggests long-term plays. High current liabilities to total assets ratio introduces risk. These trends indicate Sinopharm may not be a multi-bagger.
1
HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off
$恒生指数(800000.HK$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $荣昌生物(09995.HK$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK$ ...
Pharmaceuticals were sold off. $荣昌生物(09995.HK$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK$ ...
1
Sinopharm Group's low P/E ratio is due to investors' limited growth expectations, leading to a reduced stock price. The poor earnings outlook from analysts also contributes to its low P/E. These conditions may continue to hinder the share price.
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅